| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |